| Title | Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma. |
| Publication Type | Journal Article |
| Year of Publication | 2023 |
| Authors | Rajendran S, Hu Y, Canella A, Peterson C, Gross A, Cam M, Nazzaro M, Haffey A, Serin-Harmanci A, Distefano R, Nigita G, Wang W, Kreatsoulas D, Li Z, Sepeda JA, Sas A, Hester ME, Miller KE, Elemento O, Roberts RD, Holland EC, Rao G, Mardis ER, Rajappa P |
| Journal | Cell Rep |
| Volume | 42 |
| Issue | 3 |
| Pagination | 112197 |
| Date Published | 2023 Mar 28 |
| ISSN | 2211-1247 |
| Keywords | Animals, Brain Neoplasms, CD8-Positive T-Lymphocytes, Disease Models, Animal, Glioma, Macrophages, Mice, Sequence Analysis, RNA, Tumor Microenvironment |
| Abstract | Recent studies have shown the importance of the dynamic tumor microenvironment (TME) in high-grade gliomas (HGGs). In particular, myeloid cells are known to mediate immunosuppression in glioma; however, it is still unclear if myeloid cells play a role in low-grade glioma (LGG) malignant progression. Here, we investigate the cellular heterogeneity of the TME using single-cell RNA sequencing in a murine glioma model that recapitulates the malignant progression of LGG to HGG. LGGs show increased infiltrating CD4 and CD8 T cells and natural killer (NK) cells in the TME, whereas HGGs abrogate this infiltration. Our study identifies distinct macrophage clusters in the TME that show an immune-activated phenotype in LGG but then evolve to an immunosuppressive state in HGG. We identify CD74 and macrophage migration inhibition factor (MIF) as potential targets for these distinct macrophage populations. Targeting these intra-tumoral macrophages in the LGG stage may attenuate their immunosuppressive properties and impair malignant progression. |
| DOI | 10.1016/j.celrep.2023.112197 |
| Alternate Journal | Cell Rep |
| PubMed ID | 36871221 |
| Grant List | K08 EY029362 / EY / NEI NIH HHS / United States L40 EY029522 / EY / NEI NIH HHS / United States U54 CA232561 / CA / NCI NIH HHS / United States |
